Development of a HPLC-UV method for determination of meloxicam in human plasma and pharmaceutical dosage forms

1. Shaji J, Varkey D. Development and validation of a reverse phase-hplc method for determination of meloxicam in pharmaceutical dosage forms and human plasma. Int J Pharm Sci Rev Res. 2012;12:152-160.Search in Google Scholar

2. Kimble B, Li KM, Govendir M. Quantitation of meloxicam in the plasma of koalas (Phascolarctos cinereus) by improved high performance liquid chromatography. J Vet Sci. 2013;14:7-14.10.4142/jvs.2013.14.1.7Search in Google Scholar

3. Bandarkar FS, Vavia PR. A Stability Indicating HPLC Method for the Determination of Meloxicam in Bulk and Commercial Formulations. Tropical Journal of Pharmaceutical Research. 2009;8:257-264.Search in Google Scholar

4. Reddy MN, Murthy TK, Rajita K, Shankar DG. New Spectrophotometric Methods For The Determination Of Meloxicam. Indian J Pharm Sci. 2001;63:245-247.Search in Google Scholar

5. Zawilla NH, Abdul-Azim Mohammad M, El Kousy NM, El-Moghazy Aly SM. Determination of meloxicam in bulk and pharmaceutical formulations. J Pharm Biomed Anal. 2003;32:1135-1144.10.1016/S0731-7085(03)00232-2Search in Google Scholar

6. Murarasu AE, Mandrescu M, Spac AF, Dorneanu V. A method for the turbidity assay of meloxicam using molybdophosphoric acid. Farmacia. 2010;58:315-321.Search in Google Scholar

7. Altinoz S, Nemutlu E, Kir S. Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma. Farmaco. 2002;57:463-468.10.1016/S0014-827X(02)01239-9Search in Google Scholar

8. Nemutlu E, Kir S. Method development and validation for the analysis of meloxicam in tablets by CZE. J Pharm Biomed Anal. 2003;31:393-396.10.1016/S0731-7085(02)00641-6Search in Google Scholar

9. Zhang H, Choi H. Analysis of meloxicam by high-performance liquid chromatography with cloud-point extraction. Anal Bioanal Chem. 2008;392:947-953.10.1007/s00216-008-2333-0Search in Google Scholar

10. Rao RN, Meena S, Rao AR. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. J Pharm Biomed Anal. 2005;39:349-363.10.1016/j.jpba.2005.03.040Search in Google Scholar

11. Vignaduzzo SE, Castellano PM, Kaufman TS. Method development and validation for the simultaneous determination of meloxicam and pridinol mesylate using RP-HPLC and its application in drug formulations. J Pharm Biomed Anal. 2008;46:219-225.10.1016/j.jpba.2007.09.011Search in Google Scholar

12. Velpandian T, Jaiswal J, Bhardwaj RK, Gupta SK. Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples. J Chromatogr B Biomed Sci Appl. 2000;738:431-436.10.1016/S0378-4347(99)00537-XSearch in Google Scholar

13. Dasandi B, Shivaprakash, Saroj H, Bhat KM. LC determination and pharmacokinetics of meloxicam. J Pharm Biomed Anal. 2002;28:999-1004.10.1016/S0731-7085(02)00064-XSearch in Google Scholar

14. Rigato HM, Mendes GD, Borges NC, Moreno RA. Meloxicam determination in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS-MS) in Brazilian bioequivalence studies. Int J Clin Pharmacol Ther. 2006;44:489-498.10.5414/CPP4448917063980Search in Google Scholar

15. Sinha PK, Jeswani RM, Topagi KS, Damle MC. A validated RP-HPLC method for determination of Meloxicam in the Presence of its Impurities. International Journal of PharmTech Research. 2009;1:1051-1060.Search in Google Scholar